| Molecular Formula | C48H80N6O31 |
| Molar Mass | 1237.17 |
| Density | 1.60±0.1 g/cm3(Predicted) |
| Melting Point | >250°C (dec.) |
| Boling Point | 1652.6±65.0 °C(Predicted) |
| Specific Rotation(α) | -11.4 º (in H2O) |
| Solubility | Soluble in Water |
| Appearance | Solid |
| Color | White to Off-White |
| pKa | 12.72±0.70(Predicted) |
| Storage Condition | −20°C |
| Stability | Hygroscopic |
| MDL | MFCD00210241 |
| In vivo study | On sarcoma 180 solid tumor in ddY mice using lentinan, an antitumorβ-D-glucan, as the positive control. Hexa-N-acetylchitohexaose (100 mg/kg/day; 3 times; intravenous ) significantly inhibits the growth of this allogenic solid tumor, affording a high tumor growth-inhibition ratio (85%) at 7 days after tumor implantation. |
| Safety Description | 24/25 - Avoid contact with skin and eyes. |
| WGK Germany | 3 |
| RTECS | LZ6653000 |
| HS Code | 29400090 |
| biological activity | Hexa-N-acetylchitohexaose is an inducer of crop disease resistance and can induce the increase of soybean lignification-related enzymes and antioxidant enzyme activities. Hexa-N-acetylchitohexaose is the substrate of lysozyme. Hexa-N-acetylchitohexaose has anti-tumor effect. |
| in vivo study | on sarcoma 180 solid tumor in ddY mice using lentinan, an antitumorβ-D-glucan, as the positive control. Hexa-N-acetylchitohexaose (100 mg/kg/day; 3 times; intravenous ) significantly inhibits the growth of this allogenic solid tumor, affording a high tumor growth-inhibition ratio (85%) at 7 days after tumor implantation. |